The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Drug treatment of BPH was initially viewed with suspicion by urologists, but has gradually achieved widespread acceptance, with excellent consequences for patients. Urologists had further ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

BPH isn't prostate cancer and doesn't make you more likely to get it. There are many treatments for it, from lifestyle changes to medication to surgery. (Photo Credit: iStock/Getty Images ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Benign prostatic hyperplasia (enlarged prostate) medications Gone are the days ... There are more treatment options now than ever before. SOURCE: David Lee, MD, urologist, UCI Health, Orange ...

VIJAYAWADA: Prashanth Hospital in Vijayawada introduced Resume Water Vapour Therapy for prostate problems, a first in the ...

In this study we demonstrated that in "real life" patient adherence to BPH medication is different to that reported in clinical trials and that patients under CT abandon treatment more frequently ...

The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron) for the treatment of overactive ... on pharmacological therapy for benign prostatic hyperplasia (BPH).